{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:12:42Z","timestamp":1784988762684,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.semarthrit.2025.152691","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T01:44:51Z","timestamp":1740275091000},"page":"152691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S","title":["Update on IgG4-related periaortitis\/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4613-2116","authenticated-orcid":false,"given":"Mitsuhiro","family":"Kawano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2025.152691_bib0001","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","article-title":"New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases","volume":"19","author":"Yamada","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152691_bib0002","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3400\/avd.oa.19-00085","article-title":"Clinical and pathological characteristics of IgG4-related periaortitis\/periarteritis and retroperitoneal fibrosis diagnosed based on experts' diagnosis","volume":"12","author":"Mizushima","year":"2019","journal-title":"Ann Vasc Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152691_bib0003","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1253\/circj.CJ-24-0026","article-title":"Validation of the Diagnostic Criteria for IgG4-Related Periaortitis\/Periarteritis and Retroperitoneal Fibrosis (IgG4PA\/RPF) 2018, and proposal of a revised 2023 version for IgG4-related cardiovascular\/retroperitoneal disease","volume":"88","author":"Mizushima","year":"2024","journal-title":"Circ J."},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152691_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152691_bib0005","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar4671","article-title":"Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a retrospective multicenter study","volume":"16","author":"Mizushima","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2025.152691_bib0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.humpath.2016.05.010","article-title":"Distribution and components of interstitial inflammation and fibrosis in IgG4-related kidney disease: analysis of autopsy specimens","volume":"55","author":"Hara","year":"2016","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152691_bib0007","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/mrcr\/rxad065","article-title":"Solitary recurrence of IgG4-related giant coronary aneurysm: case report and review of the literature focusing on treatment strategies and complications","volume":"8","author":"Kawahara","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152691_bib0008","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s40744-023-00593-7","article-title":"Efficacy and safety of inebilizumab in IgG4-related disease: protocol for a randomized controlled trial","volume":"10","author":"Perugino","year":"2023","journal-title":"Rheumatol Ther"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152691_bib0009","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1016\/S2665-9913(23)00157-1","article-title":"Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial","volume":"5","author":"Perugino","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152691_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003026","article-title":"IgG4-related disease administered dupilumab: case series and review of the literature","volume":"9","author":"Kanda","year":"2023","journal-title":"RMD Open"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T03:56:41Z","timestamp":1762228601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"alternative-id":["S0049017225000629"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152691","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on IgG4-related periaortitis\/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152691"}}